MrsYan Whisler

ASO PROF

PH-PHARMTHERAPY TRNSL RSCH

  • ASO PROF
    PH-PHARMTHERAPY TRNSL RSCH

GRANTS

  • GRANT
    Cardioprotection and Risk Determinants in Cancer Patients with Immune Checkpoint Inhibitor Therapy
    American Heart Association1 Jan 2026 - 31 Dec 2027
    Active
  • GRANT
    Cardiovascular Adverse Events Related to Aromatase Inhibitors in Breast Cancer
    Florida Breast Cancer Foundation18 Jul 2024 - 30 Jun 2026
    Active
  • GRANT
    Cardiovascular Adverse Events Related to Aromatase Inhibitors in Female Breast Cancer
    National Institute of Health1 Mar 2024 - 31 Aug 2024
    Expired
  • GRANT
    Toward a Precision Medicine Approach to Medication-Related Osteonecrosis of the Jaw
    National Institute of Health Nidcr7 Sep 2021 - 6 Sep 2023
    Expired
  • GRANT
    Replication of GenHAT GWAS signals in Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) and Genetic Epidemiology of Responses to Antihypertensives (GERA)
    National Institute of Health6 Aug 2021 - 31 Aug 2021
    Expired
  • GRANT
    A Multi-omics evaluation of Carfilzomib-related Cardiotoxicity
    National Institute of Health Nhlbi12 Jul 2021 - 31 Jul 2026
    Expired
  • GRANT
    Precision antiplatelet therapy after percutaneous coronary intervention
    National Institute of Health Nhlbi15 Jun 2020 - 30 Jun 2026
    Expired
  • GRANT
    Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
    National Institute of Health Nichd24 Aug 2018 - 31 Aug 2025
    Expired
  • GRANT
    Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
    National Institute of Health Nichd16 Aug 2018 - 31 Jul 2025
    Expired
  • GRANT
    Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
    National Institute of Health Nichd1 Jun 2016 - 31 Aug 2018
    Expired
  • GRANT
    OneFlorida Clinical Research Consortium Phase II
    Patient-Centered Outcomes Research Institute8 Dec 2015 - 29 Mar 2019
    Expired